Patients taking GLP-1 drugs lose weight faster, but they may experience side effects, such as nausea, vomiting, diarrhea, indigestion, fatigue, dizziness, and hypoglycemia, along with other potential adverse events
For example, in 2008, researchers in China undertook a three-month trial to assess the hypoglycemic effect of berberine versus metformin, a common prescription used to control the blood sugar levels in people with type 2 diabetes
GHK-Cus pro-collagen signaling directly targets this mechanism
Individuals lacking lung-specific microbial communities exhibit T helper 17 (Th17)/neutrophil mucosal immune features and have weaker innate immune function, suggesting a potential immunomodulatory mechanism